InflaRx (IFRX) Non Operating Interest Expenses (2016 - 2026)
InflaRx (IFRX) reported Non Operating Interest Expenses of -$17,020 for Q2 2026, compared with -$3,798 a year earlier.
Powered by 
Analysis
InflaRx (IFRX) Non Operating Interest Expenses (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, InflaRx's Non Operating Interest Expenses came in at -$45.68 billion; for FY2025, it was -$44.33 billion.
- By year, Non Operating Interest Expenses came in at -$22.07 billion in FY2024, -$38.33 billion in FY2023, -$46.17 billion in FY2022 and -$28.34 billion in FY2021.
- Five-year quarterly Non Operating Interest Expenses spans a low of -$45.68 billion in Q4 2025 and a high of -$3,798 in Q2 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$17,338 (Q1 2026), -$45.68 billion (Q4 2025) and -$16,786 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | InflaRx | 103.29 Mn | -230.33 Mn | 2.74 Mn | -17,020.46 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17,020.46 |
| Mar 31, 2026 | -17,337.57 |
| Dec 31, 2025 | 71,052.05 |
| Sep 30, 2025 | -16,786.46 |
| Jun 30, 2025 | -3,797.72 |
| Mar 31, 2025 | -4,298.00 |
| Dec 31, 2024 | 39,036.86 |
| Sep 30, 2024 | -5,526.24 |
| Jun 30, 2024 | -9,403.38 |
| Mar 31, 2024 | -5,032.03 |
| Dec 31, 2023 | 54,984.83 |
| Sep 30, 2023 | -5,330.83 |
| Jun 30, 2023 | -5,501.25 |
| Mar 31, 2023 | -5,933.43 |
| Dec 31, 2022 | 86,339.45 |
| Sep 30, 2022 | -6,901.64 |
| Jun 30, 2022 | 8,477.77 |
| Mar 31, 2022 | -27,593.80 |
| Dec 31, 2021 | 46,937.13 |
| Sep 30, 2021 | -11,235.07 |
API Access
InflaRx Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();